EUVIMEDEUVIMED entdecken
Crossref

Direct oral anticoagulant (DOAC) levels, bleeding, and breakthrough thrombosis: fog of war

Joseph R Shaw

Journal of Thrombosis and Haemostasis · 2025-11 · 23 (11) · 3441-3444

DOI: 10.1016/j.jtha.2025.08.003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Thrombosis and Haemostasis, 2025-11. Verfasst von Joseph R Shaw. Beteiligte Einrichtung: Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada; Inflammation and Chronic Disease Program, Division of Hematology, Ottawa Hospi…. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 21 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada; Inflammation and Chronic Disease Program, Division of Hematology, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada. Electronic address: j…

Zitieren

APA

Shaw, J. R. (2025). Direct oral anticoagulant (DOAC) levels, bleeding, and breakthrough thrombosis: fog of war. Journal of Thrombosis and Haemostasis, 23(11), 3441-3444. https://doi.org/10.1016/j.jtha.2025.08.003

Vancouver

Shaw JR. Direct oral anticoagulant (DOAC) levels, bleeding, and breakthrough thrombosis: fog of war. Journal of Thrombosis and Haemostasis. 2025;23(11):3441-3444. doi:10.1016/j.jtha.2025.08.003

BibTeX
@article{Shaw2025,
  author = {Shaw, Joseph R},
  title = {Direct oral anticoagulant (DOAC) levels, bleeding, and breakthrough thrombosis: fog of war},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2025},
  volume = {23},
  number = {11},
  pages = {3441--3444},
  doi = {10.1016/j.jtha.2025.08.003}
}
Kostenlos starten →